GISEA/OEG International Symposium 2017 2-3 MARZO 2017€¦ · GISEA/OEG International Symposium...

GISEA/OEG International Symposium 2017

FERRARA2-3 MARZO 2017



SCIENTIFIC ORGANIZERS

SCIENTIFIC COMMITTEE

Giovanni LAPADULA President of GISEA(Gruppo Italiano di Studio sulla Early Arthritis) Bari (Italy)

Gianfranco FERRACCIOLI President of OEG(Osservatorio Epidemiologico GISEA)Roma (Italy)

Fabiola ATZENI - Milano (Italy)

Roberto CAPORALI - Pavia (Italy)

Ennio Giulio FAVALLI - Milano (Italy)

Marcello GOVONI - Ferrara (Italy)

Elisa GREMESE - Roma (Italy)

Florenzo IANNONE - Bari (Italy)

Fausto SALAFFI - Ancona (Italy)

Marco SEBASTIANI - Modena (Italy)



FACULTYFederico BISCETTI Roma (Italy) Paolo BONARETTI Reggio Emilia (Italy)Serena BUGATTI Pavia (Italy)Luca CANTARINI Siena (Italy)Francesco Paolo CANTATORE Foggia (Italy)Antonio CARLETTO Verona (Italy)Marina CAROTTI Jesi (Italy)Lorenzo CAVAGNA Pavia (Italy)Stefania CERRI Modena (Italy)Luca CIMINO Reggio Emilia (Italy)Fabrizio CONTI Roma (Italy)Andrea DORIA Padova (Italy)Oscar Massimiliano EPISMilano (Italy)Caterina FERRELI Cagliari (Italy)Clodoveo FERRI Modena (Italy)Rosario FOTI Catania (Italy)Enrico FUSARO Torino (Italy)Rosario GAGLIARDILecce (Italy)Mauro GALEAZZI Siena (Italy)James GALLOWAY London (UK)

Juan J. GOMEZ REINO Santiago de Compostela (Spain)Roberto GORLA Brescia (Italy)Walter GRASSI Jesi (Italy)Clive KELLY Newcastle (UK)Andreina MANFREDI Modena (Italy)Anna Maria MARATA Modena (Italy)Saverio MENNINI Roma (Italy)Carlo Maurizio MONTECUCCO Pavia (Italy)Ignazio Benedetto OLIVIERIPotenza (Italy)Giuseppe PASSIU Sassari (Italy)Raffaele PELLERITO Torino (Italy)Maria Beatrice PRINCIPI Bari (Italy)Leonardo PUNZI Padova (Italy)Roberta RAMONDA Padova (Italy) Maurizio ROSSINI Verona (Italy)Carlo SALVARANI Reggio Emilia (Italy)Piercarlo SARZI PUTTINI Milano (Italy)Luigi SINIGAGLIA Milano (Italy)Anja STRANGFELD Mannheim (Germany)Giovanni TRIOLO Palermo (Italy)Francesco TROTTA Ferrara (Italy)



SUMMARY TABLE - THURSDAY 2TH MARCH

SCIENTIFIC ECM PROGRAM SPONSORED LECTURE CORSI MONOTEMATICI

09,00 – 10,30 Sessione Corsi Monotematici No ECM La Medicina Comunicazionale

Imaging del Paziente Complesso

10,30 – 11,00 Sponsored Lecture - MSD Golimumab persistence in therapy in real life: new evidences from Italian registries

11,00 – 11,30 Sponsored Lecture - BMS Efficaciadiabataceptnellapraticaclinica

11,30 – 11,40 Apertura

SESSION I Comorbidities in Rheumatoid Arthritis: Skeletal Health

11,40 – 12,00 Rheumatoid arthritis: systemic osteoporosis and fragility fractures.

12,00 – 12,20 Pathophysiology of subchondral bone erosions in rheumatoid arthritis.

12,20 – 12,40 Therapeutic options to preserve bone health in rheumatoid arthritis. 12,40 – 12,50 Discussion

12,50 – 13,20 Lettura Nuove Terapie: Jakinibs

13,20 – 14,15 Lunch

SESSION II Infections

14,15 – 14,35 TB infections in patients with RA treated with biological agents: results from the British Register.

14,35 – 14,55 Outcome of serious infections in RA patients: results from the German Biologics Register.

14,55–15,15 Non-specificinfectionsinpatientswithRAandSpAtreatedwithbiologicalagents. 15,15 – 15,30 Discussion



SUMMARY TABLE - THURSDAY 2TH MARCH

15,30 – 16,00 Sponsored Lecture - SANOFI Quando l’anti-TNF in prima linea fallisce, quali sono le possibili scelte da intraprendere nel paziente affetto da AR (Artrite reumatoide)

16,00 – 16,30 Sponsored Lecture - ABBVIE Occhio alle spondiloartropatie

SESSION III Cardiovascular Risks

16,30 – 16,50 Corticosteroids and biotechnologic drugs in disease control and CV risk: which side hangs the balance? 16,50–17,10 Thromboembolicriskandstrokeininflammatoryarthritides.

17,10 – 17,25 Discussion

17,25 – 17,55 Sponsored Lecture - CELGENE La gestione del paziente con artrite psoriasica in assenza di fattori di prognosi severa

SESSION IV Impact on the Neurologic System

17,55 – 18,15 Peripheral neuropathy in rheumatoid arthritis: a neglected comorbidity.

18,15 – 18,35 Central nervous system and rheumatoid arthritis: not only atloepistrophic involvement. 18,35 – 18,55 Drugs and neurologic involvement in rheumatoid arthritis: myth or reality?

18.45 – 19.10 Discussion

SCIENTIFIC ECM PROGRAM

SPONSORED LECTURE

CORSI MONOTEMATICI



SUMMARY TABLE - FRIDAY 3TH MARCH

SCIENTIFIC ECM PROGRAM SPONSORED LECTURE CORSI MONOTEMATICI

09,00 – 09,30 Sponsored Lecture - PFIZER An innovative management of unmet needs in RA (rheumatoid arthritis) patients to achieve a Comprehensive Disease Control

09,30 – 10,00 Sponsored Lecture - ROCHE IL-6 inhibition in RA: tocilizumab from RCT to real world data.

SESSION V Lung Diseases

10,00 – 10,20 The need for an early diagnosis of Rheumatoid Arthritis related Interstitial Lung Disease.

10,20 – 10,40 Clinical assessment of Rheumatoid Arthritis related Interstitial Lung Disease.

10,40 – 11,00 Conventional and biological DMARDs and Rheumatoid Arthritis related Interstitial Lung Disease: the problem or the solution?


11,15–11,45 PresentazioneProgettoPatientProfiling

TAVOLA ROTONDA Which future for public health care sustainability? Regional scenarios, clinical needs and working hypothesis

11,45 – 12,05 National health care system and regional scenarios.

12,05 – 12,25 Clinical needs and expectancies.

12,25 – 12,45 Are there suitable working hypothesis solutions ?

12,45 – 13,15 Sponsored Lecture - NOVARTIS Secukinumab: tra la real life e i dati registrativi

13,15 - 13,45 Sponsored Lecture - BIOGEN Sostenibilità delle innovazioni farmacologiche : i biosimilari”

13,45 – 14,30 Lunch



SUMMARY TABLE - FRIDAY 3TH MARCH

SESSION VI Skin: a “Window of Opportunity”

14,30–14,50 IlProgettoIDEA:finalreport

14,50 – 15,20 Lettura PsA e obesità.

15,20- 15,40 Skin and Psoriatic Arthritis

15,40–16,00 SkinandInflammatoryBowelDiseases 16,00 – 16,20 Skin and Rare Diseases 16,20 – 16,35 Discussion

ECM TEST

SCIENTIFIC ECM PROGRAM

SPONSORED LECTURE

CORSI MONOTEMATICI



EDUCATIONAL AIMS

LOCATION

A number of European countries have set-up biologics registries to follow cohorts of patients treated with therapies targeting molecules, at extra-cellular and intracellular level either, which play a pivotal role in the pathogenesis of RA and Spondyloarthrtis, and record their characteristics and clinical course over time. As we are aware, these registries have begun to provide valuable insights into the optimal treatment of various rheumatic conditions that can and should be used to inform clinical decision making and to provide also important safety informations.The educational aims of this congress are to:

• Highlight the role of national biologic registers as a source of long-term, real-life data and assess the implications for clinical practice

• Review the long-term effectiveness and maintenance on therapy data from national biologic registers

• Comparing data from national biologic registers on RA and Spondyloarthritides

• To stress the value of early diagnosis and treatments

• Reanalyze the ultrasonography as a useful diagnostic tool in managing these diseases.

• Consider the safety data emerging from national biologic registers with a particular focus on serious infections, lymphoma and solid tumors.

The GISEA/OEG International Symposium 2017 will be held at the Aula Magna of the University of Ferrara, situated in: 37 Corso Ercole I d’Este, Ferrara (FE), Zip Code 44121.This marvellous building has been technologically updated in order to hold a number of conferences, conventions and events, while retaining its classical look. It is situated in the City Centre of Ferrara, surrounded by parks, and in close proximity to parking garages, restaurants, bars, and more.



ECM PROGRAM

11,30 – 11,40 Apertura

SESSION I Comorbidities in Rheumatoid Arthritis Skeletal Health CHAIRMEN: Francesco Paolo Cantatore, Carlo Salvarani, Ennio Giulio Favalli

11,40 – 12,00 Rheumatoid arthritis: systemic osteoporosis and fragility fractures. Luigi Sinigaglia, Milano 12,00 – 12,20 Pathophysiology of subchondral bone erosions in rheumatoid arthritis. Serena Bugatti, Pavia

12,20 – 12,40 Therapeutic options to preserve bone health in rheumatoid arthritis. Maurizio Rossini, Verona 12,40 – 12,50 Discussion

12,50 – 13,20 Lettura Nuove Terapie: Jakinibs SPEAKER: Luigi Sinigaglia, Milano CHAIRMEN: Giovanni Lapadula

13,20 – 14,15 LUNCH

THURSDAY 2TH MARCH



ECM PROGRAM

SESSION II Infections CHAIRMEN: Piercarlo Sarzi-Puttini - Fabiola Atzeni

14,15 – 14,35 TB infections in patients with RA treated with biological agents: results from the British Register. James Galloway, U.K.

14,35 – 14,55 Outcome of serious infections in RA patients: results from the German Biologics Register. Anja Strangfeld, Germany

14,55–15,15 Non-specificinfectionsinpatientswithRA and SpA treated with biological agents. Juan Josè Gomez Reino, Spain 15,15 – 15,30 Discussion

SESSION III Cardiovascular Risks CHAIRMEN: Florenzo Iannone, Marco Sebastiani, Elisa Gremese

16,30 – 16,50 Corticosteroids and biotechnologic drugs in disease control and CV risk: which side hangs the balance? Fabiola Atzeni, Milano

16,50-17,10 Thromboembolicriskandstrokeininflammatoryarthritides. Federico Biscetti, Roma




ECM PROGRAM

SESSION IV Impact on the Neurologic System CHAIRMEN: Mauro Galeazzi, Antonio Carletto, Roberto Caporali

17,55 – 18,15 Peripheral neuropathy in rheumatoid arthritis: a neglected comorbidity. Lorenzo Cavagna, Pavia

18,15 – 18,35 Central nervous system and rheumatoid arthritis: not only atloepistrophic involvement. Marcello Govoni, Ferrara

18,35 – 18,55 Drugs and neurologic involvement in rheumatoid arthritis: myth or reality? Fabrizio Conti, Roma 18.45 – 19.10 Discussion



ECM PROGRAM

SESSION V Lung Diseases CHAIRMEN: Andrea Doria, Roberto Gorla, Clodoveo Ferri

10,00 – 10,20 The need for an early diagnosis of Rheumatoid Arthritis related Interstitial Lung Disease. Andreina Manfredi, Modena 10,20 – 10,40 Clinical assessment of Rheumatoid Arthritis related Interstitial Lung Disease. Stefania Cerri, Modena 10,40 – 11,00 Conventional and biological DMARDs and Rheumatoid Arthritis related Interstitial Lung Disease: the problem or the solution? Clive Kelly, Newcastle (U.K.)


11,15–11,45 PresentazioneProgettoPatientProfiling SPEAKER: Ennio Giulio Favalli, Milano CHAIRMEN: Giovanni Lapadula, Gianfranco Ferraccioli

TAVOLA ROTONDA Which future for public health care sustainability? Regional scenarios, clinical needs and working hypothesis Chairmen: Marcello Govoni, Ferrara - Giovanni Lapadula, Bari

11,45 – 12,05 National health care system and regional scenarios. Anna Maria Marata, Modena

12,05 – 12,25 Clinical needs and expectancies. Marcello Govoni, Ferrara

FRIDAY 3TH MARCH



ECM PROGRAM

12,25 – 12,45 Are there suitable working hypothesis solutions? Paolo Bonaretti, Reggio Emilia Consulente del Ministero per lo Sviluppo Economico

13,45 – 14,30 Lunch

SESSION VI Skin: a “Window of Opportunity” CHAIRMEN: Giovanni Lapadula, Fabrizio Conti, Rosario Foti

14,30–14,50 IlProgettoIDEA:finalreport Fausto Salaffi, Ancona 14,50 – 15,20 Lettura PsA e obesità. Florenzo Iannone, Bari

15,20- 15,40 Skin and Psoriatic Arthritis. Caterina Ferreli, Cagliari

15,40–16,00 SkinandInflammatoryBowelDiseases. Beatrice Principi, Bari

16,00 – 16,20 Skin and Rare Diseases. Luca Cantarini, Siena 16,20 – 16,35 Discussion

ECM TEST



CORSI MONOTEMATICITHURSDAY 2TH MARCH

09,00 – 10,30 Sessione Corsi Monotematici No ECM La Medicina Comunicazionale Rosario Gagliardi, Lecce

Imaging del Paziente Complesso Fausto Salaffi, Ancona Marina Carotti, Jesi



SPONSORED LECTURES

10,30 – 11,00 Sponsored Lecture - MSD Golimumab persistence in therapy in real life: new evidences from Italian registries SPEAKER: Ennio Giulio Favalli, Milano CHAIRMEN: Carlo Maurizio Montecucco

11,00 – 11,30 Sponsored Lecture - BMS Efficaciadiabataceptnellapraticaclinica SPEAKER: Florenzo Iannone, Bari CHAIRMEN: Marcello Govoni

15,30 – 16,00 Sponsored Lecture - SANOFI Quando l’anti-TNF in prima linea fallisce, quali sono le possibili scelte da intraprendere nel paziente affetto da AR (Artrite reumatoide) SPEAKER: Ennio Giulio Favalli, Milano CHAIRMEN: Leonardo Punzi, Luca Cantarini

16,00 – 16,30 Sponsored Lecture - ABBVIE Occhio alle spondiloartropatie SPEAKER: Luca Cimino, Reggio Emilia CHAIRMEN: Andrea Doria, Enrico Fusaro

17,25 – 17,55 Sponsored Lecture - CELGENE La gestione del paziente con artrite psoriasica in assenza di fattori di prognosi severa SPEAKER: Roberto Caporali, Pavia CHAIRMEN: Giuseppe Passiu, Roberta Ramonda

THURSDAY 2TH MARCH



SPONSORED LECTURES

09,00 – 09,30 Sponsored Lecture - PFIZER An innovative management of unmet needs in RA (rheumatoid arthritis) patients to achieve a Comprehensive Disease Control SPEAKER: Fausto Salaffi, Ancona CHAIRMEN: Oscar Massimiliano Epis, Walter Grassi

09,30 – 10,00 Sponsored Lecture - ROCHE IL- 6 inhibition in RA: tocilizumab from RCT to real world data. SPEAKER: Marcello Govoni, Ferrara CHAIRMEN: Giovanni Lapadula, Francesco Trotta

12,45 – 13,15 Sponsored Lecture - NOVARTIS Secukinumab: tra la real life e i dati registrativi SPEAKER: Giovanni Lapadula, Bari CHAIRMEN: Marcello Govoni, Raffaele Pellerito

13,15 - 13,45 Sponsored Lecture - BIOGEN Sostenibilità delle innovazioni farmacologiche: i biosimilari” SPEAKER: Saverio Mennini, Roma CHAIRMEN: Piercarlo Sarzi Puttini, Giovanni Triolo

FRIDAY 3TH MARCH



LINKSBEST FOLLOWER 2017

A prize will be awarded to the medical postgraduate or young doctor showing the most dedicated partecipation on the event’s social networks

Visit our website www.gisea.eu

Subscribe toGruppodiReumatologia•RegistriGISEA/OEG,visit our showcase pageGISEA/OEG-GruppoItalianodiStudioEarlyArthritis

Visit our Facebook pageGruppoItalianoStudioEarlyArthritis-Gisea/Org

Follow @Gisea_Oeg or search #gisea2017 to join the discussion

REGISTRATION FEEThe registration fee is € 500.00 + 22% VAT (€ 610,00 VAT included), payable by bsnk transfer to th following account: Formedica Srl (IBAN CODE: IT 42 M 03268 16000 052668696720; SWIFT CODE: SELBIT2BXXX). Please send a copy of the bank transfer (by fax: +39.0832.304994 or email: [email protected]) to the Organizing Secretariat.



ECM

Continuing Medical Education (ECM)

The GISEA International Symposium 2017 will be included in the ECM program of the Italian Ministry of Health as an educational amd residential activity (n.157- 179937) for no.100 participants (discipline: Rheumatology and Internal Medicine). The Symposium has obtained no. 9 Ecm credits.Credit assignement depends on the partecipation to th whole ECM training program,as detailed below:* TUESDAY 02th March: from 11.45 am to 3.30 pm and from 4.30 pm to 5.25 pm and from 5.55 pm to 7.10 pm.* FRIDAY 03th March: from 10.00 am to 12.45 pm and from 2.30 pm to 4.35 pm..The participation of each attendee will be verified at the time of enetring and exiting throughout the duration of te Symposium. At the end of the ECM program, please com-plete the evaluation tests you have received during h regstration, and return them to the Secretariat. In order to acquire the ECM credits, please fill the registration form in all its partes clearly. An attendance certificat will be given to all participants at the end of the Symposium.



SPONSORSHIP With the non conditional support of:

GENZYME

GOLDEN SPONSOR



Date post:	03-Jun-2020
Category:	Documents
Upload:	others
View:	1 times
Download:	0 times

GISEA/OEG International Symposium 2017 2-3 MARZO 2017€¦ · GISEA/OEG International Symposium...

Documents